Immune Network Research Limited Company Profile

19:26 EST 23rd November 2017 | BioPortfolio

Profile:A Vancouver, BC - based company, Immune Network Research Ltd. identifies outstanding commercial opportunities for new drug treatments, and takes them closer to market through rapid completion of critical milestones. Completion of these milestones is followed by licensing, alliances or spin-offs in order to create maximum return on investment for our shareholders.


Immune Network Research Ltd. has established a multi-disciplinary network of world class pharmacology experts in order to carefully select candidate drugs and technology.

Each prospective candidate opportunity will have an underlying foundation of strong science, protectable intellectual property, and a clearly identifiable commercial niche.

With rapid return on investment as the underlying basis of the strategy, the acquisition of rights, the addition of value, and the rapid divestiture through licenses, alliances or spin-offs will create a wide technology portfolio targeting important diseases, including Alzheimer's disease, Asthma, and AIDS.

Immune Network Research Ltd. will differentiate itself from other biotech companies by earning a strong reputation for successful commercialization of drugs aimed at these and other mainstream diseases.

Technological and Scientific Network:

Our extensive Network of Experts communicate and exchange information using the latest advanced business tools. The core group of the Company's Network includes pharmacology experts Drs. Brian Conway, Michael Grant, Sultan Karim, Heinz Köhler, Clive Page, and Michael Walker. Each of these experts provides a fundamental contribution to the Network.

Current Portfolio:

Our strategy allows for continuous project portfolio expansion and diversification. We believe this reduces risk for shareholders. Currently, we are developing products in three therapeutic areas:

Alzheimer's Disease: Immune Network Research Ltd. has acquired rights to a patent for the use of a group of compounds, based on an existing drug approved for another disease, in the treatment of Alzheimer's disease. The company anticipates that the next milestone for this project will be Phase II clinical trials.

Asthma: Immune Network Research Ltd., along with its joint venture partner Bridge Pharma, is carrying out research on a group of novel, non-steroidal, disease modifying agents for the treatment of asthma. The next milestone for this project will be the completion of laboratory studies on this group of compounds and selection of a clinical candidate

AIDS: Immune Network Research Ltd. has recently reacquired a 100% in this project involving a monoclonal antibody (1F7) which may represent a unique advancement in the treatment of AIDS. The company's former joint venture partner, ImmPheron, has completed pre-clinical research on the 1F7 antibody. This novel approach for treating HIV infection is aimed at resetting the body's immune system to continue to fight the AIDS virus even as it mutates. Immune Network is currently preparing a regulatory package for clinical trial approval.


3650 Wesbrook Mall
British Columbia
V6S 2L2


Phone: 604 222 5541
Fax: 604 222 5542

News Articles [1130 Associated News Articles listed on BioPortfolio]

Studying immune response to aluminum salts can explain how these chemicals boost vaccine's efficacy

Adjuvants are often included in vaccines to stimulate the immune system and so make a vaccine more effective. Now an A*STAR team, led by Alessandra Mortellaro from the Singapore Immunology Network, ha...

Fish provide insight into the evolution of the immune system

(University of East Anglia) New research reveals how immune systems can evolve resistance to parasites.The study published in Nature Communications, solves the enigma of how species can adapt and chan...

Ludwig scientists discover complex axis of immune suppression exploited by cancers

(Ludwig Institute for Cancer Research) A Ludwig Cancer Research study has uncovered a new mechanism by which cancer cells evade destruction by the immune system. The paper, led by Camilla Jandus of th...

Circuit Clinical, ePatientFinder to create largest U.S. research site network

ePatientFinder, a research delivery network and leader in electronic health record (EHR) patient identification, and Circuit Clinical, a practice-based clinical research site network, announced a part...

Study identifies new metabolic target in quest to control immune response

(University of Vermont) A surprising discovery that immune cells possess an internal warehouse of glycogen used to activate immune responses could help to increase immune activity in vaccines or suppr...

A plant effector-triggered immunity signaling sector is inhibited by pattern-triggered immunity

Since signaling machineries for two modes of plant-induced immunity, pattern-triggered immunity (PTI) and effector-triggered immunity (ETI), extensively overlap, PTI and ETI signaling likely interact....

Cancer relapse linked to body's own immune system

(Institute of Cancer Research) Cancer cells that survive after treatment may use the body's own immune system to wake themselves up and fuel their growth, a new study shows. The research sheds new lig...

Appointment of Director

Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...

PubMed Articles [3930 Associated PubMed Articles listed on BioPortfolio]

Research Ethics 2.0: New Perspectives on Norms, Values, and Integrity in Genomic Research in Times of Even Scarcer Resources.

Research ethics anew gained importance due to the changing scientific landscape and increasing demands and competition in the academic field. These changes are further exaggerated because of scarce(r)...

Construction of an integrated gene regulatory network link to stress-related immune system in cattle.

The immune system is an important biological system that is negatively impacted by stress. This study constructed an integrated regulatory network to enhance our understanding of the regulatory gene n...

The highly buffered Arabidopsis immune signaling network conceals the functions of its components.

Plant immunity protects plants from numerous potentially pathogenic microbes. The biological network that controls plant inducible immunity must function effectively even when network components are t...

Sino-Austrian High-Tech Acupuncture Network-Annual Report 2015.

The Sino-Austrian High-Tech Acupuncture Research Network was founded in 2005 and has been growing ever since. The network comprises many partners from China and is highly involved in research and educ...

Sino-Austrian High-Tech Acupuncture Network-Annual Report 2016.

The Sino-Austrian High-Tech Acupuncture Research Network was founded in 2005 and has been growing ever since. The network comprises many partners from China and is highly involved in research and educ...

Clinical Trials [4163 Associated Clinical Trials listed on BioPortfolio]

Participation in a Research Registry for Immune Disorders

Background: - People with primary immune deficiency diseases (PIDD) have weak immune systems. This makes it hard for their bodies to fight infection. The Immune Deficiency Foundation has ...

French Clinical Datbase of Melanoma Patients (RIC-Mel)

With a high incidence, low survival rates and limiter availability of effective treatment, melanoma is one of the research priorities for health authorities. Optimizing the development of ...

COPD Patient-Powered Research Network

The COPD Patient-Powered Research Network (COPD PPRN) is a patient research registry with the goal of enrolling 75,000 or more COPD patients and those at risk who are willing to share thei...

Assessing Community Cancer Care After Insurance ExpanSionS

This innovative and timely study will measure the impact of Affordable Care Act (ACA) Medicaid expansions on cancer screenings and preventive services. To assess this natural policy experi...

Blood and Marrow Transplant Clinical Research Network

The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.

Companies [2150 Associated Companies listed on BioPortfolio]

Immune Network Research Limited

Profile:A Vancouver, BC - based company, Immune Network Research Ltd. identifies outstanding commercial opportunities for new drug treatments, and takes them closer to market through rapid completion ...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

BC Proteomics Network

The BC Proteomics Network (BCPN) is a growing network of researchers and informatics professionals from universities, research institutions and industry throughout British Columbia.  Formed in ...

iBridge Network

The iBridge(SM) Network is an innovation catalyst with a vibrant, online community enabling universities, companies and entrepreneurs to connect, collaborate and license tomorrow's research, products ...

National Institute for Health Research, Clinical Research Network

The Clinical Research Network is part of the National Institute for Health Research - the research arm of the National Health Service in England. The Clinical Research Network pro...

More Information about "Immune Network Research Limited" on BioPortfolio

We have published hundreds of Immune Network Research Limited news stories on BioPortfolio along with dozens of Immune Network Research Limited Clinical Trials and PubMed Articles about Immune Network Research Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immune Network Research Limited Companies in our database. You can also find out about relevant Immune Network Research Limited Drugs and Medications on this site too.

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Corporate Database Quicklinks

Searches Linking to this Company Record